336 results
Search Results
2. Cyclic Voltammetric-Paper-Based Genosensor for Detection of the Target DNA of Zika Virus
- Author
-
Anirudh Bishoyi, Md. Anish Alam, Mohd. Rahil Hasan, Manika Khanuja, Roberto Pilloton, and Jagriti Narang
- Subjects
Zika virus ,genosensor ,paper electrodes ,cross-reactivity ,synthetic serum ,Mechanical engineering and machinery ,TJ1-1570 - Abstract
Zika virus (ZIKV), a positive-sense single-stranded RNA virus, has been declared as the cause of a ‘worldwide public health emergency’ by the WHO since the year 2016. In cases of acute infections, it has been found to cause Guillain–Barre syndrome and microcephaly. Considering the tropical occurrence of the infections, and the absence of any proper treatments, accurate and timely diagnosis is the only way to control this infectious disease. Currently, there are many diagnostic methods under investigation by the scientific community, but they have some major limitations, such as high cost, low specificity, and poor sensitivity. To overcome these limitations, we have presented a low-cost, simple-to-operate, and portable diagnosis system for its detection by utilizing silver nanoparticles. silver nanoparticles were synthesized via chemical methods and characterization was confirmed by UV/TEM and XRD. The paper platform was synthesized using a graphene-based conductive ink, methylene blue as the redox indicator, and a portable potentiostat to perform the cyclic voltammetry to ensure true point-of-care availability for patients in remote areas.
- Published
- 2022
- Full Text
- View/download PDF
3. Developing a Paper-Based Antigen Assay to Differentiate between Coronaviruses and SARS-CoV-2 Spike Variants
- Author
-
Delyan R. Hristov, Jose Gomez-Marquez, Kimberly Hamad, and Hom Rijal
- Subjects
China ,Coronavirus disease 2019 (COVID-19) ,Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) ,Computational biology ,Biology ,010402 general chemistry ,medicine.disease_cause ,Cross-reactivity ,01 natural sciences ,Article ,Analytical Chemistry ,Coronavirus OC43, Human ,Signal quality ,Antigen ,Binding pattern ,medicine ,Humans ,Coronavirus ,SARS-CoV-2 ,Chemistry ,fungi ,010401 analytical chemistry ,Spike Protein ,COVID-19 ,virus diseases ,Paper based ,0104 chemical sciences ,Spike Glycoprotein, Coronavirus ,Spike (software development) ,Function (biology) - Abstract
COVID-19 first appeared in December of 2019 in Wuhan, China. Since then it has become a global pandemic. A robust and scalable diagnostics strategy is crucial for containing and monitoring the pandemic. RT-PCR is a known, reliable method for COVID-19 diagnostics which can differentiate between SARS-CoV-2 and other viruses. However, PCR is location dependent, time consuming and relatively expensive. Thus, there is a need for a more flexible method which may be produced in an off-the-shelf format and distributed more widely. Paper-based immunoassays can fulfill this function. Here we present the first steps towards a paper-based test which can differentiate between different between the Spike protein of various coronaviruses, SARS-CoV-1, SARS-CoV-2 and CoV-HKU1 with negligible cross reactivity for HCoV-OC43 and HCoV-229E in a single assay which takes less than 30 minutes. Furthermore, our test can distinguish between fractions of the same Spike protein. This is done by an altered assay design with four test line locations where each antigen builds a unique, identifiable binding pattern. The effect of several factors, such as running media, immunoprobe concentration and antigen interference is considered. We find that running media has a significant effect on the final binding pattern where human saliva provides results while human serum leads to the lowest signal quality.
- Published
- 2021
4. Development of a paper-based lateral flow immunoassay for simultaneous detection of lipopolysaccharides of Salmonella serovars
- Author
-
Lars Hecht, Florian Schenk, Patricia Weber, Andreas Dietzel, Günter Gauglitz, and Julian Vogler
- Subjects
Lipopolysaccharides ,Paper ,Salmonella typhimurium ,Serotype ,Salmonella ,Point-of-Care Systems ,Salmonella enteritidis ,Analytical chemistry ,02 engineering and technology ,medicine.disease_cause ,01 natural sciences ,Biochemistry ,Cross-reactivity ,Analytical Chemistry ,Clinical work ,medicine ,Humans ,Immunoassay ,medicine.diagnostic_test ,Chemistry ,010401 analytical chemistry ,Collodion ,Membranes, Artificial ,Equipment Design ,Paper based ,021001 nanoscience & nanotechnology ,Molecular biology ,0104 chemical sciences ,Salmonella Infections ,Colorimetry ,0210 nano-technology ,Lateral flow immunoassay - Abstract
Lateral flow type detection is becoming interesting not only in regions with a poor medical infrastructure but also for practitioners in day-to-day clinical work or for veterinary control in case of possible epidemics. In this work, we describe the first steps of development of a multi-channel strip with potential internal calibration of multiparametric and colorimetric lateral flow assays for the simultaneous detection of the lipopolysaccharides (LPS) of Salmonella typhimurium (S. typhimurium) and Salmonella enteritidis (S. enteritidis). We structured four channels in the nitrocellulose membrane with a Yb:KGW solid-state femtosecond laser ("cold" ablation process) to form distinct tracks of porous material and used gold nanoparticles for the labeling of the antibodies. In addition, calibration curves of the spot intensities of both serovars are presented, and it was shown that no cross reactivity between the different capture antibodies and LPS occurred. Finally, we detected LPS of both Salmonella serovars simultaneously. The color changes (spot intensities of the reaction zones) were evaluated using the open-source image-processing program ImageJ. Graphical abstract Multiparametric testing, strip A was tested with LPS S. enteritidis ( c=0.01 g/L) and LPS S.typhimurium ( c=0.0001 g/L), strip B with LPS S. enteritidis ( c=0.001 g/L) and LPS S. typhimurium ( c=0.001g/L) and strip C with LPS S. enteritidis (c=0.0001 g/L) and LPS S. typhimurium ( c=0.01 g/L), and read-out.
- Published
- 2017
5. Towards a more precise diagnosis of hypersensitivity to beta‐lactams – an EAACI position paper
- Author
-
Jean-Christoph Roger J-P Caubet, Anca-Mirela Chiriac, Paul Whitaker, Lene H. Garvey, Annick Barbaud, Alla Nakonechna, Andreas J. Bircher, Gülfem Çelik, María José Torres, Antonino Romano, Cristobalina Mayorga, Josefina Cernadas, Pascal Demoly, Knut Brockow, Marina Atanaskovic-Markovic, University of Catania [Italy], School of Medecine [Belgrade], University of Belgrade [Belgrade], CHU Tenon [AP-HP], Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), University Hospital Basel [Basel], Department of Dermatology and Allergy Biederstein, Technische Universität Munchen - Université Technique de Munich [Munich, Allemagne] (TUM), Geneva University Hospital (HUG), Ankara University School of Medicine [Turkey], Immunoallergy Department [Porto], Centro Hospitalar São João EPE, Faculdade de Medicina da Universidade do Porto (FMUP), Universidade do Porto, Institut Pierre Louis d'Epidémiologie et de Santé Publique (iPLESP), Sorbonne Université (SU)-Institut National de la Santé et de la Recherche Médicale (INSERM), Centre Hospitalier Régional Universitaire [Montpellier] (CHRU Montpellier), Département pneumologie et addictologie [Montpellier], Centre Hospitalier Régional Universitaire [Montpellier] (CHRU Montpellier)-Hôpital Arnaud de Villeneuve, Department of Clinical Medicine [Copenhagen], Bispebjerg Hospital-Faculty of Health and Medical Sciences, University of Copenhagen = Københavns Universitet (KU)-University of Copenhagen = Københavns Universitet (KU), Biomedical Research Institute of Málaga (IBIMA), Universidad de Málaga [Málaga] = University of Málaga [Málaga], Allergy and Immunology Clinic [Royal Liverpool and Broadgreen University Hospital], Royal Liverpool and Broadgreen University Hospital NHS Trust, University of Liverpool, Salvy-Córdoba, Nathalie, Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU), Universidade do Porto = University of Porto, Institut National de la Santé et de la Recherche Médicale (INSERM)-Sorbonne Université (SU), and University of Copenhagen = Københavns Universitet (UCPH)-University of Copenhagen = Københavns Universitet (UCPH)
- Subjects
Hypersensitivity, Immediate ,medicine.medical_specialty ,Allergy ,[SDV.IMM] Life Sciences [q-bio]/Immunology ,Referral ,cross-reactivity ,diagnosis ,Immunology ,Provocation test ,Drug allergy ,risk stratification ,Drug Hypersensitivity ,Beta-lactam ,03 medical and health sciences ,chemistry.chemical_compound ,Allergists ,0302 clinical medicine ,medicine ,Humans ,Immunology and Allergy ,guidelines ,Child ,Intensive care medicine ,Skin Tests ,030304 developmental biology ,0303 health sciences ,ddc:618 ,[SDV.MHEP] Life Sciences [q-bio]/Human health and pathology ,business.industry ,beta-lactams ,Novelty ,allergy ,medicine.disease ,Anti-Bacterial Agents ,3. Good health ,030228 respiratory system ,chemistry ,Risk stratification ,Position paper ,[SDV.IMM]Life Sciences [q-bio]/Immunology ,business ,[SDV.MHEP]Life Sciences [q-bio]/Human health and pathology - Abstract
International audience; A recent survey of the European Academy of Allergy and Clinical Immunology (EAACI) Drug Allergy Interest Group (DAIG) on how European allergy specialists deal with beta-lactam (BL) hypersensitivity demonstrated a significant heterogeneity in current practice, suggesting the need to review and update existing EAACI guidelines in order to make the diagnostic procedures as safe and accurate, but also as cost-effective, as possible. For this purpose, a bibliographic search on large studies regarding BL hypersensitivity diagnosis was performed by an EAACI task force, which reviewed and evaluated the literature data using the GRADE system for quality of evidence and strength of recommendation. The updated guidelines provide a risk stratification in BL hypersensitivity according to index reaction(s), as well as an algorithmic approach, based on cross-reactivity studies, in patients with a suspicion of BL hypersensitivity and an immediate need for antibiotic therapy, when referral to an allergist is not feasible. Furthermore, the update addresses availability and concentrations of skin test (ST) reagents, ST and drug provocation test (DPT) protocols, as well as diagnostic algorithms and administration of alternative BL in allergic subjects. Specifically, distinct diagnostic algorithms are suggested depending on risk stratification of the patient into high and low risk based on the morphology and chronology of the reaction, immediate (i.e., occurring within 1 to 6 hours after the last administered dose) or nonimmediate (i.e., occurring more than 1 hour after the initial drug administration), and the reaction severity. Regarding the allergy workup, the main novelty of this document is the fact that in some low-risk nonimmediate reactions ST are not mandatory, especially in children. For DPT, further studies are necessary to provide data supporting the standardization of protocols, especially of those regarding nonimmediate reactions, for which there is currently no consensus.
- Published
- 2019
6. Cyclic Voltammetric-Paper-Based Genosensor for Detection of the Target DNA of Zika Virus.
- Author
-
Bishoyi, Anirudh, Alam, Md. Anish, Hasan, Mohd. Rahil, Khanuja, Manika, Pilloton, Roberto, and Narang, Jagriti
- Subjects
DNA viruses ,ZIKA virus ,SILVER nanoparticles ,METHYLENE blue ,CONDUCTIVE ink ,SINGLE-stranded DNA - Abstract
Highlights: Recent report on paper-based genosensor for the diagnosis of ZIKV target DNA. Silver nanoparticles were characterized by XRD/UV-Vis/TEM. Cross-reactivity of genosensor was deduced. Electrochemical validation was performed through CV. Zika virus (ZIKV), a positive-sense single-stranded RNA virus, has been declared as the cause of a 'worldwide public health emergency' by the WHO since the year 2016. In cases of acute infections, it has been found to cause Guillain–Barre syndrome and microcephaly. Considering the tropical occurrence of the infections, and the absence of any proper treatments, accurate and timely diagnosis is the only way to control this infectious disease. Currently, there are many diagnostic methods under investigation by the scientific community, but they have some major limitations, such as high cost, low specificity, and poor sensitivity. To overcome these limitations, we have presented a low-cost, simple-to-operate, and portable diagnosis system for its detection by utilizing silver nanoparticles. silver nanoparticles were synthesized via chemical methods and characterization was confirmed by UV/TEM and XRD. The paper platform was synthesized using a graphene-based conductive ink, methylene blue as the redox indicator, and a portable potentiostat to perform the cyclic voltammetry to ensure true point-of-care availability for patients in remote areas. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
7. Minimizing antibody cross-reactivity in multiplex detection of biomarkers in paper-based point-of-care assays
- Author
-
Lara Lama, Jesper Gantelius, Helene Andersson-Svahn, and Jorge Dias
- Subjects
0301 basic medicine ,Antibody microarray ,Point-of-Care Systems ,Metal Nanoparticles ,02 engineering and technology ,Biology ,Cross Reactions ,medicine.disease_cause ,Cross-reactivity ,Sensitivity and Specificity ,03 medical and health sciences ,Antigen ,Limit of Detection ,medicine ,Humans ,General Materials Science ,Multiplex ,Ultrasonics ,Point of care ,Detection limit ,Immunoassay ,medicine.diagnostic_test ,021001 nanoscience & nanotechnology ,030104 developmental biology ,Immunology ,biology.protein ,Gold ,Antibody ,0210 nano-technology ,Antibodies, Immobilized ,Biomarkers - Abstract
Highly multiplexed immunoassays could allow convenient screening of hundreds or thousands of protein biomarkers simultaneously in a clinical sample such as serum or plasma, potentially allowing improved diagnostic accuracy and clinical management of many conditions such as autoimmune disorders, infections, and several cancers. Currently, antibody microarray-based tests are limited in part due to cross reactivity from detection antibody reagents. Here we present a strategy that reduces the cross-reactivity between nanoparticle-bound reporter antibodies through the application of ultrasound energy. By this concept, it was possible to achieve a sensitivity 10(3)-fold (5 pg mL(-1)) lower than when no ultrasound was applied (50 ng mL(-1)) for the simultaneous detection of three different antigens. The detection limits and variability achieved with this technique rival those obtained with other types of multiplex sandwich assays.
- Published
- 2016
8. Application of recombinant antigen 5 allergens from seven allergy-relevant Hymenoptera species in diagnostics.
- Author
-
Schiener, M., Eberlein, B., Moreno‐Aguilar, C., Pietsch, G., Serrano, P., McIntyre, M., Schwarze, L., Russkamp, D., Biedermann, T., Spillner, E., Darsow, U., Ollert, M., Schmidt‐Weber, C. B., and Blank, S.
- Subjects
HYMENOPTERA ,BITES & stings ,ANAPHYLAXIS ,ALLERGIES ,VENOM ,PAPER wasps ,FIRE ants - Abstract
Background Hymenoptera stings can cause severe anaphylaxis in untreated venom-allergic patients. A correct diagnosis regarding the relevant species for immunotherapy is often hampered by clinically irrelevant cross-reactivity. In vespid venom allergy, cross-reactivity between venoms of different species can be a diagnostic challenge. To address immunological IgE cross-reactivity on molecular level, seven recombinant antigens 5 of the most important Vespoidea groups were assessed by different diagnostic setups. Methods The antigens 5 of yellow jackets, hornets, European and American paper wasps, fire ants, white-faced hornets, and Polybia wasps were recombinantly produced in insect cells, immunologically and structurally characterized, and their sIgE reactivity assessed by Immuno CAP, ELISA, cross-inhibition, and basophil activation test ( BAT) in patients with yellow jacket or Polistes venom allergy of two European geographical areas. Results All recombinant allergens were correctly folded and structural models and patient reactivity profiles suggested the presence of conserved and unique B-cell epitopes. All antigens 5 showed extensive cross-reactivity in sIgE analyses, inhibition assays, and BAT. This cross-reactivity was more pronounced in Immuno CAP measurements with venom extracts than in sIgE analyses with recombinant antigens 5. Dose-response curves with the allergens in BAT allowed a differentiated individual dissection of relevant sensitization. Conclusions Due to extensive cross-reactivity in various diagnostic settings, antigens 5 are inappropriate markers for differential sIgE diagnostics in vespid venom allergy. However, the newly available antigens 5 from further vespid species and the combination of recombinant allergen-based sIgE measurements with BAT represents a practicable way to diagnose clinically relevant sensitization in vespid venom allergy. [ABSTRACT FROM AUTHOR]
- Published
- 2017
- Full Text
- View/download PDF
9. History of safe exposure and bioinformatic assessment of phosphomannose-isomerase (PMI) for allergenic risk
- Author
-
Mark E. Nelson, Rod A. Herman, Jason M. Roper, Henry P. Mirsky, Carey A. Mathesius, and Zhenglin Hou
- Subjects
0301 basic medicine ,Allergy ,Bioinformatics ,Sequence Homology ,Genetically modified crops ,Computational biology ,Biology ,Cross Reactions ,medicine.disease_cause ,Cross-reactivity ,Zea mays ,03 medical and health sciences ,0404 agricultural biotechnology ,Allergen ,Genetics ,medicine ,Humans ,Amino Acid Sequence ,Peptide sequence ,Organism ,Selectable marker ,Plant Proteins ,Original Paper ,Mannose-6-Phosphate Isomerase ,Phosphomannose Isomerase ,PMI ,Computational Biology ,04 agricultural and veterinary sciences ,Allergens ,Plants, Genetically Modified ,040401 food science ,030104 developmental biology ,Phosphomannose-isomerase ,Animal Science and Zoology ,Safety ,Risk assessment ,Agronomy and Crop Science ,Food Hypersensitivity ,Biotechnology - Abstract
Newly expressed proteins in genetically engineered crops are evaluated for potential cross reactivity to known allergens as part of their safety assessment. This assessment uses a weight-of-evidence approach. Two key components of this allergenicity assessment include any history of safe human exposure to the protein and/or the source organism from which it was originally derived, and bioinformatic analysis identifying amino acid sequence relatedness to known allergens. Phosphomannose-isomerase (PMI) has been expressed in commercialized genetically engineered (GE) crops as a selectable marker since 2010 with no known reports of allergy, which supports a history of safe exposure, and GE events expressing the PMI protein have been approved globally based on expert safety analysis. Bioinformatic analyses identified an eight-amino-acid contiguous match between PMI and a frog parvalbumin allergen (CAC83047.1). While short amino acid matches have been shown to be a poor predictor of allergen cross reactivity, most regulatory bodies require such matches be assessed in support of the allergenicity risk assessment. Here, this match is shown to be of negligible risk of conferring cross reactivity with known allergens.
- Published
- 2021
10. Sensitisation to lipid transfer proteins in pollen – allergic adults with food allergy
- Author
-
Magdalena Żbikowska-Gotz, Anna Wawrzeńczyk, Adam Wawrzeńczyk, and Zbigniew Bartuzi
- Subjects
Allergy ,cross-reactivity ,lipid transfer protein ,Dermatology ,medicine.disease_cause ,Immunoglobulin E ,Cross-reactivity ,030207 dermatology & venereal diseases ,03 medical and health sciences ,0302 clinical medicine ,Oral allergy syndrome ,Food allergy ,Immunology and Allergy ,Medicine ,Internal medicine ,Artemisia vulgaris ,Original Paper ,food allergy ,biology ,business.industry ,medicine.disease ,biology.organism_classification ,RC31-1245 ,allergenic components ,RL1-803 ,Immunology ,biology.protein ,Population study ,business ,Plant lipid transfer proteins - Abstract
Introduction Food allergy affects 6-17% of Europeans and in 60% of the cases it is accompanied by inhalation allergy. This is due to two phenomena, namely co-sensitisation and cross-reactivity, which are caused by panallergens, such as lipid transfer proteins (LTP). These proteins are classified as defence proteins PR-14 and are responsible for protecting the plant from bacterial and fungal infections. Clinically, LTP allergy manifests with severe anaphylactic reactions or milder reactions, such as oral allergy syndrome. Aim To assess the incidence of specific IgE to components belonging to LTP based on molecular testing. Material and methods The study was conducted at the Department of Allergy, Clinical Immunology and Internal Diseases in Bydgoszcz, Poland. A total of 50 subjects participated in the study. Each subject had their asIgE levels determined with ImmunoCap ISAC. Results and conclusions Antigen-specific IgE antibodies to LTP components were identified in 24% of the subjects. In subjects with LTP allergy, adverse skin reactions were the most common after consumption of sensitising foods. Peach was the most common food allergen triggering these reactions. The Artemisia vulgaris component Art v 3 was the precursor of LTP allergy in our study population: the highest incidence and the highest mean levels of asIgE were demonstrated for this component.
- Published
- 2020
11. Voltammetric-based immunosensor for the detection of SARS-CoV-2 nucleocapsid antigen
- Author
-
Mohammed Zourob, Shimaa Eissa, Maha Al-Mozaini, Hani A. Alhadrami, and Ahmed M. Hassan
- Subjects
viruses ,Metal Nanoparticles ,02 engineering and technology ,Biosensing Techniques ,Immunosensor ,medicine.disease_cause ,01 natural sciences ,Cross-reactivity ,Analytical Chemistry ,COVID-19 Testing ,Antigen ,Limit of Detection ,Nasopharynx ,medicine ,Electrochemical detection ,Coronavirus Nucleocapsid Proteins ,Humans ,Sulfhydryl Compounds ,Voltammetry ,Electrodes ,Antibody ,Detection limit ,Nucleocapsid protein ,Immunoassay ,Original Paper ,Chromatography ,medicine.diagnostic_test ,Chemistry ,SARS-CoV-2 ,010401 analytical chemistry ,Fatty Acids ,virus diseases ,COVID-19 ,Electrochemical Techniques ,021001 nanoscience & nanotechnology ,Phosphoproteins ,Carbon ,0104 chemical sciences ,Linear range ,Colloidal gold ,Gold ,0210 nano-technology ,Biosensor ,Antibodies, Immobilized - Abstract
Since the COVID-19 disease caused by the novel severe acute respiratory syndrome coronavirus 2 (SARS- CoV-2) was declared a pandemic, it has spread rapidly, causing one of the most serious outbreaks in the last century. Reliable and rapid diagnostic tests for COVID-19 are crucial to control and manage the outbreak. Here, a label-free square wave voltammetry-based biosensing platform for the detection of SARS-CoV-2 in nasopharyngeal samples is reported. The sensor was constructed on screen-printed carbon electrodes coated with gold nanoparticles. The electrodes were functionalized using 11-mercaptoundecanoic acid (MUA) which was used for the immobilization of an antibody against SARS-CoV-2 nucleocapsid protein (N protein). The binding of the immunosensor with the N protein caused a change in the electrochemical signal. The detection was realised by measuring the change in reduction peak current of a redox couple using square wave voltammetry at 0.04 V versus Ag ref. electrode on the immunosensor upon binding with the N protein. The electrochemical immunosensor showed high sensitivity with a linear range from 1.0 pg.mL−1 to 100 ng.mL−1 and a limit of detection of 0.4 pg.mL−1 for the N protein in PBS buffer pH 7.4. Moreover, the immunosensor did not exhibit significant response with other viruses such as HCoV, MERS-CoV, Flu A and Flu B, indicating the high selectivity of the sensor for SARS-CoV-2. However, cross reactivity of the biosensor with SARS-CoV is indicated, which gives ability of the sensor to detect both SARS-CoV and SARS-CoV-2. The biosensor was successfully applied to detect the SARS-CoV-2 virus in clinical samples showing good correlation between the biosensor response and the RT-PCR cycle threshold values. We believe that the capability of miniaturization, low-cost and fast response of the proposed label-free electrochemical immunosensor will facilitate the point-of-care diagnosis of COVID 19 and help prevent further spread of infection.
- Published
- 2021
12. A systematic review and meta-analysis of cross-reactivity of antibodies induced by H7 influenza vaccine
- Author
-
Junqiong Huang, Yu Shi, Ke Zhang, Xiaoqin Gou, and Xiaoxue Wu
- Subjects
Influenza vaccine ,030231 tropical medicine ,Immunology ,Influenza A Virus, H7N7 Subtype ,Hemagglutinin (influenza) ,Hemagglutinin Glycoproteins, Influenza Virus ,Antibodies, Viral ,Influenza A Virus, H7N9 Subtype ,medicine.disease_cause ,Cross-reactivity ,Virus ,Epitope ,Influenza A Virus, H7N3 Subtype ,03 medical and health sciences ,0302 clinical medicine ,systematic review ,vaccine ,Influenza, Human ,Humans ,Immunology and Allergy ,Medicine ,030212 general & internal medicine ,Seroconversion ,Pharmacology ,biology ,business.industry ,Antibodies, Neutralizing ,Virology ,meta-analysis ,Influenza Vaccines ,Meta-analysis ,biology.protein ,Influenza A Virus, H7N1 Subtype ,Antibody ,business ,H7 subtype ,Research Paper - Abstract
Inoculation with vaccine is the major intervention currently used to prevent influenza infections. However, it will be a challenge to produce and implement a new vaccine when a novel highly pathogenic influenza virus emerges in humans as significant infections. H7 subtype influenza viruses have similar epitopes on hemagglutinin, which can induce cross-reactive antibodies. In this study, a meta-analysis of the cross-reactivity of antibodies induced by one H7 subtype influenza vaccine against other H7 subtypes was performed. Database search was conducted in PubMed, Cochrane Library, EMBASE, MEDLINE, Chinese Biological Medicine Database (CBM), and Wanfang. A total of 9 articles comprising 811 human subjects were included in this meta-analysis. All assessed H7 influenza vaccines induced vaccine strain-specific protective antibodies [seroconversion rate (SCR) = 0.74, 95% CI (0.65, 0.82); seroprotection rate (SPR) = 0.81, 95% CI (0.78, 0.83)]. All H7 influenza virus monovalent vaccines exhibited cross-reactivity tested by hemagglutinin inhibition test (HI), microneutralization test (MN) and immunosorbent assay (ELISA) to other H7 subtype viruses. H7N1, H7N3, H7N7, and H7N9 vaccines elicited cross-reactive antibodies against other H7 subtype influenza viruses [SCR = 0.66, 95% CI (0.50, 0.82); SPR = 0.79, 95% CI (0.67, 0.91)]. The pooled SCR (95%CI) of cross-reactivity of H7N1 and H7N3 vaccines were 0.88 (0.85, 0.91) and 0.40 (0.26, 0.54), respectively. The consolidated SPR (95%CI) of H7N1 and H7N7 vaccines were 0.89 (0.86, 0.92) and 0.93 (0.81, 1.06). All H7 vaccines induced cross-reactive antibodies against H7N9 viruses [SCR = 0.69, 95% CI (0.52, 0.86); SPR = 0.85, 95% CI (0.76, 0.94)]. H7 vaccines can be used to limit influenza infection when a new highly pathogenic H7 virus appears.
- Published
- 2019
13. A ten-year study of immunogenicity and safety of the AS04-HPV-16/18 vaccine in adolescent girls aged 10-14 years
- Author
-
Tino F. Schwarz, Sylviane Poncelet, Li-Min Huang, Lan Lin, Naveen Karkada, Alejandra Valencia, Falko Panzer, Nicolas Folschweiller, Gary Dubin, Frank Struyf, Cheng-Hsun Chiu, and Annabelle Decreux
- Subjects
safety ,Time Factors ,cross-reactivity ,Adolescent ,viruses ,HPV-31 ,030231 tropical medicine ,Immunology ,HPV-16/18 AS04-adjuvanted vaccine ,Uterine Cervical Neoplasms ,Antibodies, Viral ,complex mixtures ,03 medical and health sciences ,0302 clinical medicine ,Immunogenicity, Vaccine ,Adjuvants, Immunologic ,Immunology and Allergy ,Medicine ,Humans ,030212 general & internal medicine ,Papillomavirus Vaccines ,Human papillomavirus ,Child ,Pharmacology ,Human papillomavirus 16 ,Human papillomavirus 18 ,business.industry ,Immunogenicity ,Papillomavirus Infections ,Vaccination ,virus diseases ,HPV-45 ,immunogenicity persistence ,Female ,business ,predictive modeling ,non-vaccine types ,Research Paper ,Follow-Up Studies - Abstract
This study assessed long-term immunogenicity and safety following 3 doses of AS04-adjuvanted human papillomavirus (HPV)-16/18 L1 virus-like particle (VLP) vaccine in females 10–14 years old. Girls included in the immunogenicity subset in the primary controlled, observer-blinded, randomized study (NCT00196924) who received 3 doses were invited for a 10-year follow-up (NCT00316706 and NCT00877877). Serum antibody responses against HPV-16/18 (vaccine types) and HPV-31/45 (non-vaccine types) were measured by enzyme-linked immunosorbent assay (ELISA) using type-specific VLP as coating antigens. Serious adverse events (SAEs) and pregnancy information were recorded. At Month (M) 120, all subjects (N = 418, according-to-protocol immunogenicity cohort) were seropositive for anti-HPV-16/18 antibodies. Geometric mean titers (GMTs) were 1589.9 ELISA Units [EU]/mL (95% confidence interval [CI]: 1459.8–1731.6) for anti-HPV-16 and 597.2 EU/mL (95% CI: 541.7–658.5) for anti-HPV-18 in subjects seronegative at baseline for the type analyzed. Post hoc mathematical modeling predicted a durability ≥50 years for anti-HPV-16 and anti-HPV-18. For the non-vaccine humoral type response, all initially seronegative subjects had seroconverted at M7, with anti-HPV-31 GMT of 2030.5 EU/mL (95% CI: 1766.2–2334.4) and anti-HPV-45 GMT of 2300.8 EU/mL (95% CI: 2036.8–2599.0). At M120, 87.7% and 85.1% remained seropositive for anti-HPV-31 with GMT of 242.9 EU/mL (95% CI: 201.4–293.0) and anti-HPV-45 with GMT of 204.7 EU/mL (95% CI: 170.0–246.6). During the 10-year follow-up, no SAEs or abnormal pregnancy outcomes were causally related to vaccination. Three doses of the AS04-HPV-16/18 vaccine induced high and sustained antibody response against HPV-16,18,31 and 45 in girls aged 10–14 years during the 10-year follow-up, with an acceptable long-term safety profile.
- Published
- 2019
14. Quantification, epitope mapping and genotype cross-reactivity of hepatitis B preS-specific antibodies in subjects vaccinated with different dosage regimens of BM32
- Author
-
Patrick Lemell, Inna Tulaeva, Milena Weber, Rainer Henning, Alexander Karaulov, René Zieglmayer, Carolin Cornelius, Petra Zieglmayer, Margarete Focke-Tejkl, Rudolf Valenta, and René Schmutz
- Subjects
0301 basic medicine ,Male ,Immunoglobulin E ,medicine.disease_cause ,Cross-reactivity ,Subclass ,Epitope ,Epitopes ,0302 clinical medicine ,Antibody Specificity ,Genotype cross-reactivity ,Vaccines ,biology ,Vaccination ,General Medicine ,Hepatitis B ,Isotype ,Recombinant Proteins ,030220 oncology & carcinogenesis ,Antibody response ,Pollen ,Female ,Antibody ,Protein Binding ,Research Paper ,Hepatitis B virus ,Genotype ,Enzyme-Linked Immunosorbent Assay ,Cross Reactions ,General Biochemistry, Genetics and Molecular Biology ,03 medical and health sciences ,Hepatitis B, Chronic ,Grass pollen allergy vaccine BM32 ,medicine ,Humans ,Hepatitis B Antibodies ,Immunization Schedule ,preS ,Hepatitis B Surface Antigens ,business.industry ,Rhinitis, Allergic, Seasonal ,Allergens ,medicine.disease ,Virology ,030104 developmental biology ,Epitope mapping ,Immunoglobulin G ,biology.protein ,business ,Epitope Mapping - Abstract
Background Chronic hepatitis B virus (HBV) infections are a global health problem. There is a need for therapeutic strategies blocking continuous infection of liver cells. The grass pollen allergy vaccine BM32 containing the preS domain of the large HBV surface protein (LHBs) as immunogenic carrier induced IgG antibodies in human subjects inhibiting HBV infection in vitro. Aim of this study was the quantification, epitope mapping and investigation of HBV genotype cross-reactivity of preS-specific antibodies in subjects treated with different dosage regimens of BM32 Methods Hundred twenty eight grass pollen allergic patients received in a double-blind, placebo-controlled trial five monthly injections of placebo (aluminum hydroxide, n= 34) or different courses of BM32 (2 placebo + 3 BM32, n= 33; 1 placebo + 4 BM32, n= 30; 5 BM32, n= 31). Recombinant Escherichia coli-expressed preS was purified. Overlapping peptides spanning preS and the receptor-binding sites from consensus sequences of genotypes A–H were synthesized and purified. Isotype (IgM, IgG, IgA, IgE) and IgG subclass (IgG1-IgG4) responses to preS and peptides were determined by ELISA at baseline, one and four months after the last injection. IgG1 and IgG4 subclass concentrations specific for preS and the receptor-binding site were measured by quantitative ELISA. Findings Five monthly injections induced the highest levels of preS-specific IgG consisting mainly of IgG1 and IgG4, with a sum of median preS-specific IgG1 and IgG4 concentrations of >135 μg/ml reaching up to 1.8 mg/ml. More than 20% of preS-specific IgG was directed against the receptor-binding site. BM32-induced IgG cross-reacted with the receptor-binding domains from all eight HBV genotypes A-H. Interpretation BM32 induces high levels of IgG1 and IgG4 antibodies against the receptor binding sites of all eight HBV genotypes and hence might be suitable for therapeutic HBV vaccination. Funding This study was supported by the PhD program IAI (KPW01212FW), by Viravaxx AG and by the Danube-ARC funded by the Government of Lower Austria. Rudolf Valenta is a recipient of a Megagrant of the Government of the Russian Federation, grant No 14.W03.31.0024.
- Published
- 2020
15. Allergen false-detection using official bioinformatic algorithms
- Author
-
Ping Song and Rod A. Herman
- Subjects
0106 biological sciences ,0301 basic medicine ,cross-reactivity ,Genetically modified crops ,Biology ,medicine.disease_cause ,01 natural sciences ,03 medical and health sciences ,Allergen ,medicine ,Amino Acid Sequence ,Plant Proteins ,Dietary exposure ,selectivity ,Computational Biology ,bioinformatics ,Allergens ,030104 developmental biology ,exposure ,False detection ,Agronomy and Crop Science ,Algorithm ,Algorithms ,010606 plant biology & botany ,Food Science ,Biotechnology ,Research Paper - Abstract
Bioinformatic amino acid sequence searches are used, in part, to assess the potential allergenic risk of newly expressed proteins in genetically engineered crops. Previous work has demonstrated that the searches required by government regulatory agencies falsely implicate many proteins from rarely allergenic crops as an allergenic risk. However, many proteins are found in crops at concentrations that may be insufficient to cause allergy. Here we used a recently developed set of high-abundance non-allergenic proteins to determine the false-positive rates for several algorithms required by regulatory bodies, and also for an alternative 1:1 FASTA approach previously found to be equally sensitive to the official sliding-window method, but far more selective. The current investigation confirms these earlier findings while addressing dietary exposure.
- Published
- 2020
16. Glycan and Peptide IgE Epitopes of the TNF-alpha Blockers Infliximab and Adalimumab - Precision Diagnostics by Cross-Reactivity Immune Profiling of Patient Sera
- Author
-
Andreas Frey, Thomas A.E. Platts-Mills, Arne Homann, Arno Kromminga, Niels Röckendorf, and Uta Jappe
- Subjects
0301 basic medicine ,Medicine (miscellaneous) ,precision medicine ,Cross Reactions ,medicine.disease_cause ,Immunoglobulin E ,Cross-reactivity ,Epitope ,Epitopes ,Pharmacovigilance ,03 medical and health sciences ,medicine ,Adalimumab ,Humans ,Pharmacology, Toxicology and Pharmaceutics (miscellaneous) ,biology ,Tumor Necrosis Factor-alpha ,business.industry ,Infliximab ,3. Good health ,anti-drug antibodies ,030104 developmental biology ,Epitope mapping ,Antirheumatic Agents ,Immunology ,biology.protein ,Peptide microarray ,hypersensitivity ,Antibody ,business ,Research Paper ,medicine.drug - Abstract
Biological drugs like therapeutic antibodies are widely used for the treatment of various diseases like inflammatory disorders and cancer. A drawback of these novel treatments is the substantial proportion of patients experiencing adverse reactions such as loss-of-drug effect or hypersensitivity reactions. These reactions are associated with pre-existing and/or developing anti-drug antibodies. Especially IgE development is a risk factor for life-threatening systemic anaphylaxis. Methods: In order to characterize the individual drug-specific serum IgE, an IgE cross-reactivity immune profiling (ICRIP) assay was developed. Individual IgG epitopes of anti-drug antibodies against adalimumab were identified by epitope mapping via peptide microarray. Results: ICRIP analyses of sera from patients treated with the therapeutic antibodies adalimumab (ADL) and infliximab (IFX) reveal individual, distinct IgE binding patterns. IgG epitopes were identified mostly located in the variable region of ADL. Conclusions: Using ICRIP and peptide microarrays for pharmacovigilance of the TNF-α blockers IFX and ADL, risk factors and biomarkers before and during therapy shall be identified. These diagnostic systems provide the basis for a safe and efficacious therapy decision for each patient in cases of adverse drug reactions mediated by different types of anti-drug antibodies.
- Published
- 2017
17. Protective Role of Cross-Reactive CD8 T Cells Against Dengue Virus Infection
- Author
-
Kevin R. King, Hui-Wen Chen, John Sidney, Yunichel Joo, Daniela Weiskopf, Alessandro Sette, William W. Tang, Annie Elong Ngono, and Sujan Shresta
- Subjects
0301 basic medicine ,Male ,DENV, dengue virus ,lcsh:Medicine ,Dengue virus ,CD8-Positive T-Lymphocytes ,medicine.disease_cause ,Ab, antibody ,Epitope ,Dengue fever ,Dengue ,Mice ,0302 clinical medicine ,Cytotoxic T cell ,Original antigenic sin ,PBMC, Peripheral Blood Mononuclear Cells ,lcsh:R5-920 ,ADE, antibody dependent enhancement ,Vaccination ,virus diseases ,General Medicine ,3. Good health ,medicine.anatomical_structure ,Phenotype ,NS, non-structural ,Cytokines ,Female ,lcsh:Medicine (General) ,Research Paper ,DHF, dengue hemorrhagic fever ,Secondary infection ,T cell ,T cells ,Mice, Transgenic ,DSS, dengue shock syndrome ,Biology ,Cross Reactions ,Serogroup ,General Biochemistry, Genetics and Molecular Biology ,03 medical and health sciences ,medicine ,Animals ,Antibody-dependent enhancement ,IFN, interferon ,Immunodominant Epitopes ,HLA, human leukocyte antigen ,lcsh:R ,Cross-reactivity ,biochemical phenomena, metabolism, and nutrition ,Dengue Virus ,medicine.disease ,Virology ,Disease Models, Animal ,030104 developmental biology ,HLA-B Antigens ,Immunology ,030215 immunology ,ICS, intracellular cytokine staining - Abstract
Infection with one of the four dengue virus serotypes (DENV1-4) presumably leads to lifelong immunity against the infecting serotype but not against heterotypic reinfection, resulting in a greater risk of developing Dengue Hemorrhagic Fever/Dengue Shock Syndrome (DHF/DSS) during secondary infection. Both antibodies and T cell responses have been implicated in DHF/DSS pathogenesis. According to the T cell-based hypothesis termed “original antigenic sin,” secondary DENV infection is dominated by non-protective, cross-reactive T cells that elicit an aberrant immune response. The goal of our study was to compare the roles of serotype-specific and cross-reactive T cells in protection vs. pathogenesis during DENV infection in vivo. Specifically, we utilized IFN-α/βR−/− HLA*B0702 transgenic mice in the context of peptide vaccination with relevant human CD8 T cell epitopes. IFN-α/βR−/− HLA*B0702 transgenic mice were immunized with DENV serotype 2 (DENV2)-specific epitopes or variants found in any of the other three serotypes (DENV1, DENV3 or DENV4), followed by challenge with DENV. Although cross-reactive T cell responses were lower than responses elicited by serotype-specific T cells, immunization with either serotype-specific or variant peptide epitopes enhanced viral clearance, demonstrating that both serotype-specific and cross-reactive T cells can contribute to protection in vivo against DENV infection., Highlights • Serotype-cross-reactive CD8 T cells elicit a polyfunctional immune response similar to the response elicited by serotype-specific CD8 T cells. • Serotype cross-reactive CD8 T cells play a role in protection against DENV infection in a HLA-B*0702 Transgenic IFN-α/βR−/− mouse model. There are four major subtypes (serotypes) of the mosquito-borne Dengue virus. Infection with a first serotype is generally asymptomatic, but secondary infection with a different serotype is capable of causing severe disease. T cells previously exposed to a first serotype and which produce an immune response to a second serotype are said to be cross-reactive. Using a mouse model engineered with human T cell features, we characterized the cross-reactive T cell response to live dengue virus serotypes and viral protein fragments. Our results suggested cross-reactive T cells contribute to control of and protection against infection by a second dengue serotype, rather than leading to more severe disease.
- Published
- 2016
- Full Text
- View/download PDF
18. A method for semi-automated image analysis of HLA class I tumour epithelium expression in rectal cancer
- Author
-
Alexander L. Vahrmeijer, Vaios Evangelou, Daniëlle Krijgsman, Ronald L.P. van Vlierberghe, Peter J. K. Kuppen, Cornelis J.H. van de Velde, and Cornelis F. M. Sier
- Subjects
0301 basic medicine ,Histology ,Stromal cell ,cross-reactivity ,medicine.medical_treatment ,Biophysics ,Human leukocyte antigen ,Epithelium ,Automated image analysis ,tumour epithelium ,Antibodies, Monoclonal, Murine-Derived ,Mice ,03 medical and health sciences ,0302 clinical medicine ,MHC class I ,Biomarkers, Tumor ,medicine ,Animals ,Humans ,lcsh:QH301-705.5 ,Original Paper ,Tissue microarray ,biology ,Rectal Neoplasms ,business.industry ,Histocompatibility Antigens Class I ,biomarkers ,Cell Biology ,Immunotherapy ,Immunohistochemistry ,030104 developmental biology ,medicine.anatomical_structure ,lcsh:Biology (General) ,Tissue Array Analysis ,030220 oncology & carcinogenesis ,biology.protein ,Cancer research ,Rabbits ,Antibody ,digital pathology ,business - Abstract
Biomarkers may hold the key towards development and improvement of personalized cancer treatment. For instance, tumour expression of immune system-related proteins may reveal the tumour immune status and, accordingly, determine choice for type of immunotherapy. Therefore, objective evaluation of tumour biomarker expression is needed but often challenging. For instance, human leukocyte antigen (HLA) class I tumour epithelium expression is cumbersome to quantify by eye due to its presence on both tumour epithelial cells and tumour stromal cells, as well as tumour-infiltrating immune cells. In this study, we solved this problem by setting up an immunohistochemical (IHC) double staining using a tissue microarray (TMA) of rectal tumours wherein HLA class I expression was coloured with a blue chromogen, whereas non-epithelial tissue was visualized with a brown chromogen. We subsequently developed a semi-automated image analysis method that identified tumour epithelium as well as the percentage of HLA class I-positive tumour epithelium. Using this technique, we compared HCA2/HC10 and EMR8-5 antibodies for the assessment of HLA class I tumour expression and concluded that EMR8-5 is the superior antibody for this purpose. This IHC double staining can in principle be used for scoring of any biomarker expressed by tumour epithelium.
- Published
- 2019
19. Immunodietica: A data-driven approach to investigate interactions between diet and autoimmune disorders
- Author
-
Leonardo M. R. Ferreira and Iosif M. Gershteyn
- Subjects
lcsh:Immunologic diseases. Allergy ,Autoimmune disease ,Research paper ,Future studies ,Immunology ,Cross-reactivity ,Autoimmunity ,Biology ,medicine.disease ,medicine.disease_cause ,Epitope ,Diet ,Pathogenesis ,Epitopes ,Gershteyn-Ferreira index ,medicine ,Immunology and Allergy ,lcsh:RC581-607 - Abstract
Autoimmunity is on the rise around the globe. Diet has been proposed as a risk factor for autoimmunity and shown to modulate the severity of several autoimmune disorders. Yet, the interaction between diet and autoimmunity in humans remains largely unstudied. Here, we systematically interrogated commonly consumed animals and plants for peptide epitopes previously implicated in human autoimmune disease. A total of fourteen species investigated could be divided into three broad categories regarding their content in human autoimmune epitopes, which we represented using a new metric, the Gershteyn-Ferreira index (GF index). Strikingly, pig contains a disproportionately high number of unique autoimmune epitopes compared to all other species analyzed. This work uncovers a potential new link between pork consumption and autoimmunity in humans and lays the foundation for future studies on the impact of diet on the pathogenesis and progression of autoimmune disorders., Highlights • We developed a comprehensive database of dietary-human autoimmune epitope overlap. • The Gershteyn-Ferreira index divides dietary antigens into three main groups with respect to overlap with human autoimmune epitopes. • Pig contains a disproportionately high number of unique human autoimmune epitopes.
- Published
- 2019
20. Genomics of Shrimp Allergens and Beyond.
- Author
-
Li, Shanshan, Chu, Ka Hou, and Wai, Christine Yee Yan
- Subjects
ALLERGENS ,SHELLFISH ,SHRIMPS ,IMMUNOGLOBULIN E ,TECHNOLOGICAL innovations ,GENOMICS ,ALLERGIES - Abstract
Allergy to shellfishes, including mollusks and crustaceans, is a growing health concern worldwide. Crustacean shellfish is one of the "Big Eight" allergens designated by the U.S. Food and Drug Administration and is the major cause of food-induced anaphylaxis. Shrimp is one of the most consumed crustaceans triggering immunoglobulin E (IgE)-mediated allergic reactions. Over the past decades, the allergen repertoire of shrimp has been unveiled based on conventional immunodetection methods. With the availability of genomic data for penaeid shrimp and other technological advancements like transcriptomic approaches, new shrimp allergens have been identified and directed new insights into their expression levels, cross-reactivity, and functional impact. In this review paper, we summarize the current knowledge on shrimp allergens, as well as allergens from other crustaceans and mollusks. Specific emphasis is put on the genomic information of the shrimp allergens, their protein characteristics, and cross-reactivity among shrimp and other organisms. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
21. The role of cross-reactive immunity to emerging coronaviruses: Implications for novel universal mucosal vaccine design.
- Author
-
Alturaiki, Wael
- Subjects
CORONAVIRUSES ,COMMON cold ,BACTERIAL vaccines ,TALL-1 (Protein) ,COVID-19 pandemic ,IMMUNITY ,VACCINES - Abstract
Copyright of Saudi Medical Journal is the property of Saudi Medical Journal and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
- Published
- 2023
- Full Text
- View/download PDF
22. Genetic and antigenic characterization of recombinant nucleocapsid proteins derived from canine coronavirus and canine respiratory coronavirus in China
- Author
-
Wenjie Tan, Yingzhu Chen, Yongliang Lou, Jianfang Zhou, Shuai Lu, and Kun Qin
- Subjects
0301 basic medicine ,China ,Antigenicity ,Genes, Viral ,cross-reactivity ,Blotting, Western ,030106 microbiology ,medicine.disease_cause ,General Biochemistry, Genetics and Molecular Biology ,law.invention ,03 medical and health sciences ,Dogs ,Coronavirus, Canine ,Western blot ,Environmental Science(all) ,law ,expression ,medicine ,Animals ,Amino Acid Sequence ,Cloning, Molecular ,canine respiratory coronavirus ,Antigens, Viral ,Escherichia coli ,Gene ,Polyacrylamide gel electrophoresis ,Phylogeny ,General Environmental Science ,Antiserum ,Sequence Homology, Amino Acid ,Agricultural and Biological Sciences(all) ,biology ,medicine.diagnostic_test ,Biochemistry, Genetics and Molecular Biology(all) ,virus diseases ,Canine coronavirus ,Nucleocapsid Proteins ,biology.organism_classification ,Virology ,canine coronavirus ,030104 developmental biology ,Recombinant DNA ,Electrophoresis, Polyacrylamide Gel ,General Agricultural and Biological Sciences ,nucleocapsid protein ,Research Paper - Abstract
To characterize the antigenicity of nucleocapsid proteins (NP) derived from canine coronavirus (CCoV) and canine respiratory coronavirus (CRCoV) in China, the N genes of CCoV (CCoV-BJ70) and CRCoV (CRCoV-BJ202) were cloned from swabs obtained from diseased pet dogs in Beijing and then sequenced. The recombinant NPs (rNPs) were expressed in Escherichia coli and purified by nickel-affinity column and size exclusion chromatography. Sequencing data indicated that the N genes of CCoV-BJ70 and CRCoV-BJ202 belonging to two distinctly different groups were relatively conserved within each subgroup. Sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) results showed that rNPs of CCoV and CRCoV were expressed efficiently and isolated with a final purity of over 95%. Western blot analysis revealed the rNP from CRCoV could cross-react with mice antisera against human coronavirus (HCoV-229E, NL63, OC43, HKU1), while rNP of CCoV had cross-reactivity with only anti-sera against viruses belonging to the same group (HCoV-229E and NL63). In summary, CCoV and CRCoV rNPs were successfully expressed in E. coli and showed antigenic cross-reactivity with antisera raised against human coronaviruses. These findings indicate that further serologic studies on coronavirus infections at the animal-human interface are needed.
- Published
- 2016
23. Safety, immunogenicity and cross-reactivity of a Northern hemisphere 2013–2014 seasonal trivalent inactivated split influenza virus vaccine, Anflu®
- Author
-
Liqun Huo, Yonggang Shen, Xiaoci Ji, Weidong Yin, Wei Li, Yufei Song, Wenjun Du, Yuansheng Hu, Zhenping Fu, and Fan-Ya Meng
- Subjects
Adult ,Male ,0301 basic medicine ,Adolescent ,Influenza vaccine ,Immunology ,Cross Reactions ,Antibodies, Viral ,Influenza A Virus, H7N9 Subtype ,medicine.disease_cause ,Cross-reactivity ,Young Adult ,03 medical and health sciences ,Immunogenicity, Vaccine ,Influenza A Virus, H1N1 Subtype ,0302 clinical medicine ,Influenza, Human ,Humans ,Immunology and Allergy ,Medicine ,030212 general & internal medicine ,Pharmacology ,business.industry ,Incidence ,Influenza A Virus, H3N2 Subtype ,Immunogenicity ,Infant ,Cross reactions ,Hemagglutination Inhibition Tests ,Middle Aged ,Research Papers ,Virology ,Influenza B virus ,030104 developmental biology ,Vaccines, Inactivated ,Influenza Vaccines ,Child, Preschool ,Female ,Seasons ,Influenza virus vaccine ,business - Abstract
Anflu® is a seasonal trivalent inactivated split-virion influenza vaccine manufactured by Sinovac Biotech Co., Ltd. The objectives of this study were to evaluate the safety of Anflu® (2013–14 formulation: H1N1, H3N2 and BYAM) in infants and adults and its immunogenicity and cross-reactivity against mismatched influenza B lineage and avian influenza A(H7N9) viruses (hereafter BVIC and H7N9, respectively) in adults. In this phase IV open label trial, infants 6–35 months old (n=61) each received two injections with 28 days apart; adults 18–60 yrs old (n=60) and elderly >60 yrs old (n=61) each received one injection. Information of adverse events was collected through safety observation and follow-up visits. Pre- and post-immune blood samples (day 0 and 21) were collected from subjects ≥18 yrs old to detect hemagglutination inhibition antibody titers and calculate seroprotection rates (SPRs) and seroconversion rates (SCRs). The overall adverse reaction incidence was 1.6% (3/182), and no serious adverse event was reported during the study period. For subjects ≥18 yrs old, the SCRs, SPRs, and the geometric mean titers (GMTs) met the European criteria for all three strains. In addition, the point estimations of SCR, SPR and GMT for BVIC also met the European criteria. Six subjects were seroconverted against H7N9; however the serological results did not meet the European criteria. In conclusion, the results showed a satisfactory safety and immunogenicity profile of Anflu® and cross-reactivity against BVIC, but did not demonstrate cross-reactivity against H7N9 (Clinicaltrials.gov ID: NCT02269852).
- Published
- 2016
24. A diagnostic one-step real-time reverse transcription polymerase chain reaction method for accurate detection of influenza virus type A
- Author
-
Abdolvahab Alborzi, Mohammad Amin Behzadi, and Mazyar Ziyaeyan
- Subjects
0301 basic medicine ,business.industry ,030106 microbiology ,detection ,General Medicine ,medicine.disease_cause ,Cross-reactivity ,Virology ,Virus ,Reverse transcription polymerase chain reaction ,one-step real-time polymerase chain reaction ,03 medical and health sciences ,GenBank ,Influenza A virus ,medicine ,influenza A virus ,Methods paper/New methods ,Primer (molecular biology) ,business ,Direct fluorescent antibody ,Nested polymerase chain reaction - Abstract
Introduction Influenza A is known as a public health concern worldwide. In this study, a novel one-step real-time reverse transcription polymerase chain reaction (rtRT-PCR) assay was designed and optimized for the detection of influenza A viruses. Material and methods The primers and probe were designed based on the analysis of 90 matrix nucleotide sequence data of influenza type A subtypes from the GenBank database of the National Center for Biotechnology Information (NCBI). The influenza virus A/Tehran/5652/2010 (H1N1 pdm09) was used as a reference. The rtRT-PCR assay was optimized, compared with that of the World Health Organization (WHO), and its analytical sensitivity, specificity and reproducibility were evaluated. In total, 64 nasopharyngeal swabs from patients with influenza-like illness (ILI) and 41 samples without ILI symptoms were tested for the virus, using conventional cell culture, direct immunofluorescence antibody (DFA) methods, and one-step rtRT-PCR with the designed primer set and probe and the WHO’s. Results The optimized assay results were similar to the WHO’s. The optimized assay results were similar to WHO’s, with non-significant differences for 10–103 copies of viral RNA/reaction (p > 0.05). It detected 10 copies of viral RNA/reaction with high reproducibility and no cross reactivity with other respiratory viruses. A specific cytopathic effect was observed in 6/64 (9.37%) of the ILI group using conventional culture and DFA staining methods; however, it was not seen in non-ILI. Also, the results of our assay and the WHO’s were similar to those of viral isolation and DFA staining. Conclusions Given the high specificity, sensitivity and reproducibility of this novel assay, it can serve as a reliable diagnostic tool for the detection of influenza A viruses in clinical specimens and lab experiments.
- Published
- 2016
25. Single dose vaccination of the ASO3-adjuvanted A(H1N1)pdm09 monovalent vaccine in health care workers elicits homologous and cross-reactive cellular and humoral responses to H1N1 strains
- Author
-
John Wood, Rebecca Jane Cox, Åsne Jul-Larsen, Rishi D. Pathirana, Emanuele Montomoli, Sarah Lartey, and Fan Zhou
- Subjects
Male ,Hemagglutination Inhibition Tests ,pandemic influenza ,Time Factors ,cross-reactivity ,alpha-Tocopherol ,Polysorbates ,medicine.disease_cause ,Antibodies, Viral ,Cross-reactivity ,AS03 ,0302 clinical medicine ,Influenza A Virus, H1N1 Subtype ,Immunologic ,Influenza A Virus ,Immunology and Allergy ,Interferon gamma ,Viral ,030212 general & internal medicine ,Memory B cell ,0303 health sciences ,Immunity, Cellular ,ELISPOT ,H1N1 ,Humoral ,virus diseases ,Middle Aged ,3. Good health ,Vaccination ,Drug Combinations ,Influenza Vaccines ,HCW ,Tumor necrosis factor alpha ,Female ,Human ,medicine.drug ,Research Paper ,Adult ,Squalene ,Health Personnel ,Immunology ,Cross Reactions ,Antibodies ,03 medical and health sciences ,Interferon-gamma ,Adjuvants, Immunologic ,Influenza, Human ,medicine ,Humans ,H1N1 Subtype ,Adjuvants ,Immunization Schedule ,030304 developmental biology ,Pharmacology ,business.industry ,healthcare workers ,Immunity ,Healthcare workers ,Immune responses ,Pandemic influenza ,Immunity, Humoral ,vaccination ,Virology ,Influenza ,immune responses ,Cellular ,business - Abstract
Healthcare workers (HCW) were prioritized for vaccination during the 2009 influenza A(H1N1)pdm09 pandemic. We conducted a clinical trial in October 2009 where 237 HCWs were immunized with a AS03-adjuvanted A(H1N1)pdm09 monovalent vaccine. In the current study, we analyzed the homologous and cross-reactive H1N1 humoral responses using prototype vaccine strains dating back to 1977 by the haemagglutinin inhibition (HI), single radial hemolysis SRH), antibody secreting cell (ASC) and memory B cell (MBC) assays. The cellular responses were assessed by interferon-γ (IFN-γ) ELISPOT and by intracellular staining (ICS) for the Th1 cytokines IFN-γ, interleukin-2 (IL-2) and tumor necrosis factor-α (TNF-α). All assays were performed using blood samples obtained prior to (day 0) and 7, 14 and 21 d post-pandemic vaccination, except for ASC (day 7) and ICS (days 0 and 21). Vaccination elicited rapid HI, SRH and ASC responses against A(H1N1)pdm09 which cross reacted with seasonal H1N1 strains. MBC responses were detected against the homologous and seasonal H1N1 strains before vaccination and were boosted 2 weeks post-vaccination. An increase in cellular responses as determined by IFN-γ ELISPOT and ICS were observed 1–3 weeks after vaccination. Collectively, our data show that the AS03-adjuvanted A(H1N1)pdm09 vaccine induced rapid cellular and humoral responses against the vaccine strain and the response cross-reacted against prototype H1N1 strains dating back to 1977. publishedVersion
- Published
- 2015
26. Comparison of recombinant cathepsins L1, L2, and L5 as ELISA targets for serodiagnosis of bovine and ovine fascioliasis
- Author
-
M.J. Perteguer, Marta González-Warleta, Florencio M. Ubeira, Ricardo A. Orbegozo-Medina, Ana Hernández-González, Esperanza Paniagua, F. Romarís, Victoria Martínez-Sernández, Teresa Gárate, and Mercedes Mezo
- Subjects
0301 basic medicine ,medicine.medical_specialty ,Fascioliasis ,Cathepsin L ,030231 tropical medicine ,Antibodies, Helminth ,Cattle Diseases ,Sheep Diseases ,Enzyme-Linked Immunosorbent Assay ,Cross Reactions ,medicine.disease_cause ,Cross-reactivity ,Sensitivity and Specificity ,law.invention ,Cathepsin ,03 medical and health sciences ,0302 clinical medicine ,Medical microbiology ,Antigen ,Hepatica ,law ,parasitic diseases ,medicine ,Fasciola hepatica ,Animals ,Serologic Tests ,Original Paper ,Serodiagnosis ,Sheep ,General Veterinary ,biology ,General Medicine ,biology.organism_classification ,Virology ,Recombinant Proteins ,030104 developmental biology ,Infectious Diseases ,Antibody response ,Insect Science ,Antigens, Helminth ,Antibody Formation ,Recombinant DNA ,Parasitology ,Cattle ,Female ,ELISA - Abstract
Infections caused by Fasciola hepatica are of great importance in the veterinary field, as they cause important economic losses to livestock producers. Serodiagnostic methods, typically ELISA (with either native or recombinant antigens), are often used for early diagnosis. The use of native antigens, as in the MM3-SERO ELISA (commercialized as BIO K 211, BIO-X Diagnostics), continues to be beneficial in terms of sensitivity and specificity; however, there is interest in developing ELISA tests based on recombinant antigens to avoid the need to culture parasites. Of the antigens secreted by adult flukes, recombinant procathepsin L1 (rFhpCL1) is the most commonly tested in ELISA to date. However, although adult flukes produce three different clades of CLs (FhCL1, FhCL2, and FhCL5), to our knowledge, the diagnostic value of recombinant FhCL2 and FhCL5 has not yet been investigated. In the present study, we developed and tested three indirect ELISAs using rFhpCL1, rFhpCL2, and rFhpCL5 and evaluated their recognition by sera from sheep and cattle naturally infected with F. hepatica. Although the overall antibody response to these three rFhpCLs was similar, some animals displayed preferential recognition for particular rFhpCLs. Moreover, for cattle sera, the highest sensitivity was obtained using rFhpCL2 (97%), being equal for both rFhpCL1 and rFhpCL5 (87.9%), after adjusting cut-offs for maximum specificity. By contrast, for sheep sera, the sensitivity was 100% for the three rFhpCLs. Finally, the presence of truncated and/or partially unfolded molecules in antigen preparations is postulated as a possible source of cross-reactivity.
- Published
- 2017
27. Quality Issues of Research Antibodies
- Author
-
Michael G. Weller
- Subjects
0301 basic medicine ,replication ,Evidence-based practice ,cross-reactivity ,media_common.quotation_subject ,lcsh:Analytical chemistry ,Clinical science ,Review ,Bioinformatics ,01 natural sciences ,Biochemistry ,Health informatics ,Analytical Chemistry ,03 medical and health sciences ,reproducibility crisis ,ligand binding assay ,Medicine ,Quality (business) ,immunoassay ,Medical journal ,quality control ,media_common ,lcsh:QD71-142 ,irreproducibility ,business.industry ,010401 analytical chemistry ,non-specific binding ,selectivity ,Public relations ,paper retraction ,0104 chemical sciences ,Variety (cybernetics) ,Medical Laboratory Technology ,030104 developmental biology ,monoclonal antibody ,Informatics ,immunochemistry ,Cancer gene ,business - Abstract
According to several recent studies, an unexpectedly high number of landmark papers seem to be not reproducible by independent laboratories. Nontherapeutic antibodies used for research, diagnostic, food analytical, environmental, and other purposes play a significant role in this matter. Although some papers have been published offering suggestions to improve the situation, they do not seem to be comprehensive enough to cover the full complexity of this issue. In addition, no obvious improvements could be noticed in the field as yet. This article tries to consolidate the remarkable variety of conclusions and suggested activities into a more coherent conception. It is concluded that funding agencies and journal publishers need to take first and immediate measures to resolve these problems and lead the way to a more sustainable way of bioanalytical research, on which all can rely with confidence.
- Published
- 2016
28. Cross-React: a new structural bioinformatics method for predicting allergen cross-reactivity
- Author
-
Werner Braun and Surendra S. Negi
- Subjects
0301 basic medicine ,Statistics and Probability ,Sequence alignment ,Computational biology ,Biology ,Cross Reactions ,medicine.disease_cause ,Crystallography, X-Ray ,Biochemistry ,Cross-reactivity ,Epitope ,Antibodies ,03 medical and health sciences ,Structural bioinformatics ,Epitopes ,Allergen ,Antigen ,immune system diseases ,medicine ,otorhinolaryngologic diseases ,Animals ,Humans ,Amino Acid Sequence ,Amino Acids ,Databases, Protein ,Molecular Biology ,Peptide sequence ,chemistry.chemical_classification ,Computational Biology ,Proteins ,respiratory system ,Allergens ,Bees ,Original Papers ,Computer Science Applications ,Amino acid ,respiratory tract diseases ,Computational Mathematics ,030104 developmental biology ,Computational Theory and Mathematics ,chemistry ,Cattle ,Sequence Alignment - Abstract
The phenomenon of cross-reactivity between allergenic proteins plays an important role to understand how the immune system recognizes different antigen proteins. Allergen proteins are known to cross-react if their sequence comparison shows a high sequence identity which also implies that the proteins have a similar 3D fold. In such cases, linear sequence alignment methods are frequently used to predict cross-reactivity between allergenic proteins. However, the prediction of cross-reactivity between distantly related allergens continues to be a challenging task. To overcome this problem, we developed a new structure-based computational method, Cross-React, to predict cross-reactivity between allergenic proteins available in the Structural Database of Allergens (SDAP). Our method is based on the hypothesis that we can find surface patches on 3D structures of potential allergens with amino acid compositions similar to an epitope in a known allergen. We applied the Cross-React method to a diverse set of seven allergens, and successfully identified several cross-reactive allergens with high to moderate sequence identity which have also been experimentally shown to cross-react. Based on these findings, we suggest that Cross-React can be used as a predictive tool to assess protein allergenicity and cross-reactivity. Availability and Implementation: Cross-React is available at: http://curie.utmb.edu/Cross-React.html
- Published
- 2016
29. Clinical Use of the ImmunoCAP Inhibition Test in the Diagnosis of Meat Allergy Caused by a Tick Bite in an Adult Male with No Previous Atopic History.
- Author
-
Lis, Kinga, Ukleja-Sokołowska, Natalia, Karwowska, Kornelia, Wernik, Joanna, Pawłowska, Małgorzata, and Bartuzi, Zbigniew
- Subjects
FOOD allergy ,ALLERGIES ,DIAGNOSIS ,POULTRY as food ,ALLERGENS ,IMMUNOGLOBULINS ,VENOM ,IMMUNOGLOBULIN E - Abstract
(1) Background: alpha-gal syndrome (AGS) is a serious, potentially life-threatening allergic reaction. This is a type of food allergy to red meat and other mammalian products (e.g., gelatin). In Poland, this problem seems to be rare or, more likely, very underdiagnosed. The diagnosis of AGS is difficult. It seems that the knowledge about this syndrome is insufficient. There are no effective diagnostic tools able to clearly diagnose this cross-reactive allergy. This paper presents the clinical application of a non-standard method in the diagnosis of a cross-reactive allergy using the example of AGS. (2) Methods: standard tests for in vitro allergy diagnostics and the non-standard ImmunoCAP inhibition test(IT) were carried out for serum collected from a patient with a red meat allergy. (3) Results: the serum concentration of anti-α-Gal IgE was very high (302 kUA/L), and IgE antibodies toanti-mammalian-meat allergens were found. The level of IgE antibodies to mammalian meat allergens decreased after blocking on α-GAL-CAP. The concentration of anti-α-Gal IgE decreased after blocking on CAPs coated with various mammalian meat allergens. Blocking with allergens of poultry meat did not affect the concentration of anti-α-Gal IgE. (4) Conclusions: the ImmunoCAP ITseems to be a useful tool in the diagnosis of cross-reactive allergies. Based on their clinical history and test results, the patient was diagnosed with AGS caused by a primary sensitization to α-Gal after a tick bite. This is the second case of AGS described in Poland and the first in Pomerania. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
30. Differentiating of cross-reactions in patients with latex allergy with the use of ISAC test
- Author
-
Ewa Jassem, Anna Różyło, Agata Kolakowska, Krzysztof Specjalski, and Marta Chełmińska
- Subjects
0301 basic medicine ,lcsh:Internal medicine ,Allergy ,cross-reactivity ,ISAC test ,Dermatology ,Immunoglobulin E ,medicine.disease_cause ,Cross-reactivity ,030207 dermatology & venereal diseases ,03 medical and health sciences ,0302 clinical medicine ,lcsh:Dermatology ,medicine ,Immunology and Allergy ,In patient ,Food allergens ,latex allergy ,lcsh:RC31-1245 ,Sensitization ,Original Paper ,biology ,business.industry ,Cross reactions ,lcsh:RL1-803 ,medicine.disease ,030104 developmental biology ,medicine.anatomical_structure ,Latex allergy ,Immunology ,biology.protein ,business - Abstract
Introduction : Differentiating between cross-reactivity and double sensitization is still a challenging issue in allergology. Aim : To differentiate cross-reactions accompanying latex allergy with the use of the ISAC test. Material and methods : Thirty-nine patients reporting immediate allergic reactions to latex were enrolled into the study (group A). The control group was comprised of 41 patients with allergic diseases not associated with latex (group B) and 20 healthy individuals (group C). Their history was recorded and skin prick tests were performed with latex, airborne and food allergens. Specific IgE against food allergens, latex (k82) and recombined latex allergens were determined. Immun o CAP ISAC test was performed with 103 molecules. Results : Sensitization to latex was found by means of skin tests in 16 cases and sIgE against latex was revealed in 12 cases (including 10 positive in both SPT and sIgE). In the ISAC test antibodies against recombined latex allergens were found in 8 patients with rHev β 6 as the most common. All the patients positive for rHev β 1, 5, 6, 8 had allergy or asymptomatic sensitization to food allergens cross-reacting with latex. Some reactions could not have been differentiated due to the lack of allergens in the ISAC test. Others, not related to latex-fruits syndrome were explained by cross-reactivity with other profilins or PR-10 proteins. Conclusions : Immun o CAP ISAC test could be useful in differentiating between cross-reactions and double sensitizations. However, in the case of latex its advantages are limited due to a small panel of allergens.
- Published
- 2014
31. The Anti-Glucocorticoid Receptor Antibody Clone 5E4: Raising Awareness of Unspecific Antibody Binding.
- Author
-
Ehlers, Lisa, Kirchner, Marieluise, Mertins, Philipp, Strehl, Cindy, Buttgereit, Frank, and Gaber, Timo
- Subjects
RECEPTOR antibodies ,MOLECULAR cloning ,IMMUNOGLOBULINS ,TRANSCRIPTION factors ,GLUCOCORTICOID receptors ,MONOCLONAL antibodies - Abstract
Unspecific antibody binding takes a significant toll on researchers in the form of both the economic burden and the disappointed hopes of promising new therapeutic targets. Despite recent initiatives promoting antibody validation, a uniform approach addressing this issue has not yet been developed. Here, we demonstrate that the anti-glucocorticoid receptor (GR) antibody clone 5E4 predominantly targets two different proteins of approximately the same size, namely AMP deaminase 2 (AMPD2) and transcription intermediary factor 1-beta (TRIM28). This paper is intended to generate awareness of unspecific binding of well-established reagents and advocate the use of more rigorous verification methods to improve antibody quality in the future. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
32. Quality Issues of Research Antibodies.
- Author
-
Weller, Michael G.
- Subjects
IMMUNOGLOBULINS ,FOOD chemistry ,DIAGNOSTIC imaging ,IMMUNOCHEMISTRY ,QUALITY control - Abstract
According to several recent studies, an unexpectedly high number of landmark papers seem to be not reproducible by independent laboratories. Nontherapeutic antibodies used for research, diagnostic, food analytical, environmental, and other purposes play a significant role in this matter. Although some papers have been published offering suggestions to improve the situation, they do not seem to be comprehensive enough to cover the full complexity of this issue. In addition, no obvious improvements could be noticed in the field as yet. This article tries to consolidate the remarkable variety of conclusions and suggested activities into a more coherent conception. It is concluded that funding agencies and journal publishers need to take first and immediate measures to resolve these problems and lead the way to a more sustainable way of bioanalytical research, on which all can rely with confidence. [ABSTRACT FROM AUTHOR]
- Published
- 2016
- Full Text
- View/download PDF
33. Revisiting Latex-Fruit Syndrome after 30 Years of Research: A Comprehensive Literature Review and Description of Two Cases.
- Author
-
Gromek, Weronika, Kołdej, Natalia, Świtała, Szymon, Majsiak, Emilia, and Kurowski, Marcin
- Subjects
LITERATURE reviews ,SYMPTOMS ,RUBBER ,PAPAYA ,ALLERGENS - Abstract
Thirty years have passed since the concept of latex-fruit syndrome (LFS) was first introduced. Since then, this phenomenon, characterized by cross-reactivity between natural latex rubber allergens and certain fruit allergens, has been extensively studied. This literature review sought to determine the prevalence of LFS in latex-allergic patients, identify the most common cross-reactions with fruit allergens in individuals with LFS, and understand the clinical manifestations of this syndrome. An extensive literature search was carried out using PubMed and Scopus databases, while applying the Preferred Reporting Items for Systematic Reviews and Meta-Analysis methodology. The analysis of original studies revealed a wide variation in LFS prevalence (4–88%) influenced by diverse diagnostic tools, different geographical regions, and the size of study populations. Our findings indicate that the most prevalent allergenic fruits in patients with LFS are banana, avocado, kiwifruit, and papaya. After evaluating the symptoms of the fruit hypersensitivity of patients with LFS, the clinical manifestation of hypersensitivity constituted 73% of systemic allergy symptoms and only 27% of reported symptoms described the localized allergy. Furthermore, the clinical picture of latex-fruit syndrome is illustrated through two cases, one typical and one with an unusual presentation. Their clinical features were assessed and contrasted utilizing different anaphylaxis severity grading criteria. To properly manage LFS, it is essential to establish standardized diagnostic criteria and severity grading systems, as these are crucial for accurate diagnosis and effective treatment. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
34. Neglected but Clinically Relevant Allergens in Korea
- Author
-
Jeong, Kyoung Yong and Park, Jung-Won
- Published
- 2024
- Full Text
- View/download PDF
35. 万古霉素和替考拉宁致交叉过敏的个案报道及文献回顾.
- Author
-
郑冠濠, 曹利, 陈尔真, and 何娟
- Abstract
Copyright of Pharmaceutial Care & Research is the property of Editorial Board of Pharmaceutial Care & Research and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
- Published
- 2018
- Full Text
- View/download PDF
36. Adverse reaction to Ficus Carica: reported case of a possible cross-reactivity with Der p1
- Author
-
Urbani, S., Aruanno, A., and Nucera, E.
- Published
- 2020
- Full Text
- View/download PDF
37. Diagnosing and managing patients with drug hypersensitivity.
- Author
-
Fernandez, Javier and Doña, Inmaculada
- Subjects
DRUG side effects ,SKIN tests ,IDIOSYNCRATIC drug reactions ,VIRUS diseases ,DIAGNOSIS - Abstract
Introduction: Diagnosing and managing drug hypersensitivity is challenging because there are no clear limits between different types of drug reactions. Distinguishing between type A (predictable) and type B (hypersensitivity) reactions when a drug is introduced on the market is not easy. When many people use a drug, adverse reactions can occur, conditioned by diverse genetic profiles, viral infections or concomitant therapy. Occasionally the only tool clinicians have on which to base the diagnosis is the clinical history. Skins tests orin vitrotests sometimes have low sensitivity or are unavailable, and drug provocation tests may be dangerous or strictly forbidden in case of severe cutaneous reactions. Areas covered: This paper reviews the diagnosis and management of the two main types of immunological reactions: IgE-mediated immediate drug hypersensitivity reactions (IDHRs) and non-immediate drug hypersensitivity reactions (NIDHRs). Expert commentary: Although Europe and the United States use different diagnostic methods, patients with history of drug hypersensitivity must avoid the suspicious drug, and clinicians must assess tolerance to safe alternatives under medical surveillance. Sometimes desensitization may be required. There is a consensus about the need to perform genetic testing for specific drugs and give patients proper documentation to prevent future exposure to culprit drugs. [ABSTRACT FROM AUTHOR]
- Published
- 2018
- Full Text
- View/download PDF
38. A highly effective ferritin-based divalent nanoparticle vaccine shields Syrian hamsters against lethal Nipah virus.
- Author
-
Chunhong Yin, Yan Feng Yao, Peipei Yang, Hang Liu, Ge Gao, Yun Peng, Miaoyu Chen, Mingqing Lu, Xuekai Zhang, Weiwei Guo, Zihan Zhang, Xue Hu, Zhiming Yuan, and Chao Shan
- Subjects
NIPAH virus ,GOLDEN hamster ,NANOPARTICLES ,RABIES virus ,PARAMYXOVIRUSES ,HENIPAVIRUSES ,VACCINES ,AUJESZKY'S disease virus - Abstract
The Nipah virus (NiV), a highly deadly bat-borne paramyxovirus, poses a substantial threat due to recurrent outbreaks in specific regions, causing severe respiratory and neurological diseases with high morbidity. Two distinct strains, NiV-Malaysia (NiV-M) and NiV-Bangladesh (NiV-B), contribute to outbreaks in different geographical areas. Currently, there are no commercially licensed vaccines or drugs available for prevention or treatment. In response to this urgent need for protection against NiV and related henipaviruses infections, we developed a novel homotypic virus-like nanoparticle (VLP) vaccine co-displaying NiV attachment glycoproteins (G) from both strains, utilizing the self-assembling properties of ferritin protein. In comparison to the NiV G subunit vaccine, our nanoparticle vaccine elicited significantly higher levels of neutralizing antibodies and provided complete protection against a lethal challenge with NiV infection in Syrian hamsters. Remarkably, the nanoparticle vaccine stimulated the production of antibodies that exhibited superior cross-reactivity to homologous or heterologous henipavirus. These findings underscore the potential utility of ferritin-based nanoparticle vaccines in providing both broad-spectrum and long-term protection against NiV and emerging zoonotic henipaviruses challenges. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
39. Utilizing the Banana S-Adenosyl-L-Homocysteine Hydrolase Allergen to Identify Cross-Reactive IgE in Ryegrass-, Latex-, and Kiwifruit-Allergic Individuals.
- Author
-
Đurašinović, Tatjana, Lopandić, Zorana, Protić-Rosić, Isidora, Ravnsborg, Tina, Blagojević, Gordan, Burazer, Lidija, Jensen, Ole N., and Gavrović-Jankulović, Marija
- Subjects
BANANAS ,FOOD allergy ,ALLERGENS ,RYEGRASSES ,AMINO acid sequence ,IMMUNOGLOBULIN E ,ESCHERICHIA coli ,POLLINATION ,FOOD safety - Abstract
Food allergies mediated by specific IgE (sIgE) have a significant socioeconomic impact on society. Evaluating the IgE cross-reactivity between allergens from different allergen sources can enable the better management of these potentially life-threatening adverse reactions to food proteins and enhance food safety. A novel banana fruit allergen, S-adenosyl-L-homocysteine hydrolase (SAHH), has been recently identified and its recombinant homolog was heterologously overproduced in E. coli. In this study, we performed a search in the NCBI (National Center for Biotechnology Information) for SAHH homologs in ryegrass, latex, and kiwifruit, all of which are commonly associated with pollen-latex-fruit syndrome. In addition, Western immunoblot analysis was utilized to identify the cross-reactive IgE to banana SAHH in the sera of patients with a latex allergy, kiwifruit allergy, and ryegrass allergy. ClustalOmega analysis showed more than 92% amino acid sequence identity among the banana SAHH homologs in ryegrass, latex, and kiwifruit. In addition to five B-cell epitopes, in silico analysis predicted eleven T-cell epitopes in banana SAHH, seventeen in kiwifruit SAHH, twelve in ryegrass SAHH, and eight in latex SAHH, which were related to the seven-allele HLA reference set (HLA-DRB1*03:01, HLA-DRB1*07:01, HLA-DRB1*15:01, HLA-DRB3*01:01, HLA-DRB3*02:02, HLA-DRB4*01:01, HLA-DRB5*01:01). Four T-cell epitopes were identical in banana and kiwifruit SAHH (positions 328, 278, 142, 341), as well as banana and ryegrass SAHH (positions 278, 142, 96, and 341). All four SAHHs shared two T-cell epitopes (positions 278 and 341). In line with the high amino acid sequence identity and B-cell epitope homology among the analyzed proteins, the cross-reactive IgE to banana SAHH was detected in three of three latex-allergic patients, five of six ryegrass-allergic patients, and two of three kiwifruit-allergic patients. Although banana SAHH has only been studied in a small group of allergic individuals, it is a novel cross-reactive food allergen that should be considered when testing for pollen-latex-fruit syndrome. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
40. IgE-Mediated Allergy and Asymptomatic Sensitization to Cannabis Allergens—Review of Current Knowledge and Presentation of Six Cases.
- Author
-
Wąsik, Jakub, Likońska, Aleksandra, and Kurowski, Marcin
- Subjects
ALLERGENS ,ALLERGIES ,ITCHING ,ANAPHYLAXIS ,MEDICAL personnel ,POLLEN - Abstract
Cannabis allergy is a relatively new phenomenon described in the 1970s. Its increased frequency has been observed over the last years due to the increasing therapeutic and recreational use of cannabis-based products. Sensitization possibly leading to allergy symptoms can occur not only through the smoking of cannabis, but also through ingestion, the inhalation of pollen, or direct contact. The severity of symptoms varies from benign pruritus to anaphylaxis. There is scant information available to support clinicians throughout the entire therapeutic process, starting from diagnosis and ending in treatment. In this review, we present six cases of patients in whom molecular in vitro testing revealed sensitization to cannabis extract and/or cannabis-derived nsLTP molecules (Can s 3). Based on these cases, we raise important questions regarding this topic. The article discusses current proposals and highlights the importance of further research not only on cannabis allergy but also on asymptomatic sensitization to cannabis allergens, which may be ascertained in some percentage of the population. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
41. Enhancement of NETosis by ACE2-cross-reactive anti-SARS-CoV-2 RBD antibodies in patients with COVID-19.
- Author
-
Hsieh, Kun-Han, Chao, Chiao-Hsuan, Cheng, Yi-Ling, Lai, Yen-Chung, Chuang, Yung-Chun, Wang, Jen-Ren, Chang, Sui-Yuan, Hung, Yuan-Pin, Chen, Yi-Ming Arthur, Liu, Wei-Lun, Chuang, Woei-Jer, and Yeh, Trai-Ming
- Subjects
COVID-19 ,CORONAVIRUS spike protein ,PROTEIN domains ,PROGNOSIS ,FC receptors ,CORONAVIRUS diseases - Abstract
Background: High levels of neutrophil extracellular trap (NET) formation or NETosis and autoantibodies are related to poor prognosis and disease severity of COVID-19 patients. Human angiotensin-converting enzyme 2 (ACE2) cross-reactive anti-severe acute respiratory syndrome coronavirus 2 spike protein receptor-binding domain (SARS-CoV-2 RBD) antibodies (CR Abs) have been reported as one of the sources of anti-ACE2 autoantibodies. However, the pathological implications of CR Abs in NET formation remain unknown. Methods: In this study, we first assessed the presence of CR Abs in the sera of COVID-19 patients with different severity by serological analysis. Sera and purified IgG from CR Abs positive COVID-19 patients as well as a mouse monoclonal Ab (mAb 127) that can recognize both ACE2 and the RBD were tested for their influence on NETosis and the possible mechanisms involved were studied. Results: An association between CR Abs levels and the severity of COVID-19 in 120 patients was found. The CR Abs-positive sera and IgG from severe COVID-19 patients and mAb 127 significantly activated human leukocytes and triggered NETosis, in the presence of RBD. This NETosis, triggered by the coexistence of CR Abs and RBD, activated thrombus-related cells but was abolished when the interaction between CR Abs and ACE2 or Fc receptors was disrupted. We also revealed that CR Abs-induced NETosis was suppressed in the presence of recombinant ACE2 or the Src family kinase inhibitor, dasatinib. Furthermore, we found that COVID-19 vaccination not only reduced COVID-19 severity but also prevented the production of CR Abs after SARS-CoV-2 infection. Conclusions: Our findings provide possible pathogenic effects of CR Abs in exacerbating COVID-19 by enhancing NETosis, highlighting ACE2 and dasatinib as potential treatments, and supporting the benefit of vaccination in reducing disease severity and CR Abs production in COVID-19 patients. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
42. Vaccine- and natural infection-induced mechanisms that could modulate vaccine safety
- Author
-
Ronald N. Kostoff, Darja Kanduc, Alan L. Porter, Yehuda Shoenfeld, Daniela Calina, Michael B. Briggs, Demetrios A. Spandidos, and Aristidis Tsatsakis
- Subjects
COVID-19 pandemic ,Vaccine safety ,Autoimmunity ,Molecular mimicry ,Cross-Reactivity ,Immune interference ,Toxicology. Poisons ,RA1190-1270 - Abstract
A degraded/dysfunctional immune system appears to be the main determinant of serious/fatal reaction to viral infection (for COVID-19, SARS, and influenza alike). There are four major approaches being employed or considered presently to augment or strengthen the immune system, in order to reduce adverse effects of viral exposure. The three approaches that are focused mainly on augmenting the immune system are based on the concept that pandemics/outbreaks can be controlled/prevented while maintaining the immune-degrading lifestyles followed by much of the global population. The fourth approach is based on identifying and introducing measures aimed at strengthening the immune system intrinsically in order to minimize future pandemics/outbreaks.Specifically, the four measures are: 1) restricting exposure to virus; 2) providing reactive/tactical treatments to reduce viral load; 3) developing vaccines to prevent, or at least attenuate, the infection; 4) strengthening the immune system intrinsically, by a) identifying those factors that contribute to degrading the immune system, then eliminating/reducing them as comprehensively, thoroughly, and rapidly as possible, and b) replacing the eliminated factors with immune-strengthening factors.This paper focuses on vaccine safety. A future COVID-19 vaccine appears to be the treatment of choice at the national/international level. Vaccine development has been accelerated to achieve this goal in the relatively near-term, and questions have arisen whether vaccine safety has been/is being/will be compromised in pursuit of a shortened vaccine development time. There are myriad mechanisms related to vaccine-induced, and natural infection-induced, infections that could adversely impact vaccine effectiveness and safety. This paper summarizes many of those mechanisms.
- Published
- 2020
- Full Text
- View/download PDF
43. Stochastic descriptors to study the fate and potential of naive T cell clonotypes in the periphery.
- Author
-
Artalejo, J., Gómez-Corral, A., López-García, M., and Molina-París, C.
- Subjects
T cell receptors ,CLONE cells ,HOMEOSTASIS ,CELL proliferation ,STOCHASTIC analysis ,MATHEMATICAL models - Abstract
The population of naive T cells in the periphery is best described by determining both its T cell receptor diversity, or number of clonotypes, and the sizes of its clonal subsets. In this paper, we make use of a previously introduced mathematical model of naive T cell homeostasis, to study the fate and potential of naive T cell clonotypes in the periphery. This is achieved by the introduction of several new stochastic descriptors for a given naive T cell clonotype, such as its maximum clonal size, the time to reach this maximum, the number of proliferation events required to reach this maximum, the rate of contraction of the clonotype during its way to extinction, as well as the time to a given number of proliferation events. Our results show that two fates can be identified for the dynamics of the clonotype: extinction in the short-term if the clonotype experiences too hostile a peripheral environment, or establishment in the periphery in the long-term. In this second case the probability mass function for the maximum clonal size is bimodal, with one mode near one and the other mode far away from it. Our model also indicates that the fate of a recent thymic emigrant (RTE) during its journey in the periphery has a clear stochastic component, where the probability of extinction cannot be neglected, even in a friendly but competitive environment. On the other hand, a greater deterministic behaviour can be expected in the potential size of the clonotype seeded by the RTE in the long-term, once it escapes extinction. [ABSTRACT FROM AUTHOR]
- Published
- 2017
- Full Text
- View/download PDF
44. Nimesulide-Induced Fixed Drug Eruption Followed by Etoricoxib-Induced Fixed Drug Eruption: An Unusual Case Report and Review of the Literature.
- Author
-
Makris, Michael, Papapostolou, Niki, Koumprentziotis, Ioannis-Alexios, Pappa, Georgia, and Katoulis, Alexander C.
- Subjects
LITERATURE reviews ,DRUG allergy ,ANTI-inflammatory agents ,BLISTERS ,PHYSICIANS ,DRUG eruptions - Abstract
Fixed drug eruption (FDE) is a well-recognized, non-immediate, drug hypersensitivity reaction, often attributed to the use of various medications, most commonly non-steroidal anti-inflammatory drugs (NSAIDs) and antibiotics. Cross-reactivity between related NSAIDs in FDE has been reported, but among chemically unrelated NSAIDs, is rare. Herein, we present a rare well-documented case where a patient initially displayed tolerance to etoricoxib after experiencing a nimesulide-induced FDE. Subsequently, the patient developed an etoricoxib-induced FDE, accompanied by the development of bullous lesions. This case report and the literature review on comparable FDE occurrences shed light on the intricate nature of FDEs, suggesting the possibility of cross-reactivity between chemically related and unrelated NSAIDs or the emergence of new drug-specific T cells without cross-reactivity after multiple exposures to a drug in a susceptible patient. Our case underscores the importance of increased awareness and vigilance among both physicians and patients in the realm of personalized medicine. Further research is needed to unravel the intricate mechanisms behind these drug eruptions, improve diagnostic approaches, and enhance patient care. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
45. Allergen Diversity and Abundance in Different Tissues of the Redclaw Crayfish (Cherax quadricarinatus).
- Author
-
Jerry, Emily M., Karnaneedi, Shaymaviswanathan, Ruethers, Thimo, Jerry, Dean R., Condon, Kelly, and Lopata, Andreas L.
- Subjects
CRAYFISH ,DERMATOPHAGOIDES ,IMMUNOGLOBULIN E ,ALLERGENS ,LIQUID chromatography-mass spectrometry ,IMMUNOGLOBULINS ,CALCIUM-binding proteins ,PROTEIN binding ,CARRIER proteins - Abstract
Shellfish allergy affects ~2.5% of the global population and is a type I immune response resulting from exposure to crustacean and/or molluscan proteins. The Australian Redclaw crayfish (Cherax quadricarinatus) is a freshwater species endemic to and farmed in northern Australia and is becoming an aquaculture species of interest globally. Despite being consumed as food, allergenic proteins from redclaw have not been identified or characterised. In addition, as different body parts are often consumed, it is conceivable that redclaw tissues vary in allergenicity depending on tissue type and function. To better understand food-derived allergenicity, this study characterised allergenic proteins in various redclaw body tissues (the tail, claw, and cephalothorax) and how the stability of allergenic proteins was affected through cooking (raw vs. cooked tissues). The potential of redclaw allergens to cross-react and cause IgE-binding in patients allergic to other shellfish (i.e., shrimp) was also investigated. Raw and cooked extracts were prepared from each body part. SDS-PAGE followed by immunoblotting was performed to determine allergen-specific antibody reactivity to sarcoplasmic calcium-binding protein and hemocyanin, as well as to identify redclaw proteins binding to IgE antibodies from individual and pooled sera of shrimp-allergic patients. Liquid chromatography-mass spectrometry (LC/MS) was utilised to identify proteins and to determine the proportion within extracts. Known crustacean allergens were found in all tissues, with a variation in tissue distribution (e.g., higher levels of hemocyanin in the claw and cephalothorax than in the tail). The proportion of some allergens as a percentage of remaining heat-stable proteins increased in cooked tissues. Previously described heat-stable allergens (i.e., hemocyanin and sarcoplasmic calcium-binding protein) were found to be partially heat-labile. Immunoblotting indicated that shrimp-allergic patients cross-react to redclaw allergens. IgE-binding bands, analysed by LC/MS, identified up to 11 known shellfish allergens. The findings of this study provide fundamental knowledge into the diagnostic and therapeutic field of shellfish allergy. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
46. Cross-reactivity features of deoxynivalenol (DON)-targeted immunoaffinity columns aiming to achieve simultaneous analysis of DON and major conjugates in cereal samples.
- Author
-
Gonçalves, Carlos and Stroka, Joerg
- Subjects
DEOXYNIVALENOL ,IMMUNOAFFINITY chromatography ,CEREALS as food ,MYCOTOXINS ,BINDING sites - Abstract
Immunoaffinity columns (IACs) are a well-established tool in the determination of regulated mycotoxins in food and feed commodities. However, they also have the potential to become attractive pre-concentration and clean-up materials for the determination of masked (also called modified) mycotoxins, which have been recognised as important contributors to the toxicological hazard deriving from fungal spoilage of goods. However, the information available in the literature concerning the cross-reactivity of DON-IACs against the major conjugates (DON-3-G, 15-AcDON and 3-AcDON) is incomplete and often contradictory. We have carried out a detailed characterisation of the cross-reactivity of the four main IACs brands against DON and its conjugates as well as an assessment of the competition among the analytes. Only one IAC enabled the simultaneous analysis of all relevant DON forms while two missed 15-AcDON and the fourth one missed DON-3-G and 3-AcDON. In the case of the multivalent IAC, the analytes modified at the C-3 position compete for the antibody binding with preference for 3-AcDON (less spatially hindered) while DON-3-G has the more-hindered access to the active sites. Taking into consideration the levels of DON conjugates existing in real samples, the cross-reactivity of one DON-IAC allows a quantitative analysis of all of these analytes. Important but rather neglected aspects such as the continuous supply of IACs with identical characteristics, and of columns which are strictly blank, are also addressed in this paper. [ABSTRACT FROM AUTHOR]
- Published
- 2016
- Full Text
- View/download PDF
47. ALERGIZUJĄCE WŁAŚCIWOŚCI JABŁEK - PODSTAWY MOLEKULARNE, CZYNNIKI WPŁYWAJĄCE NA POZIOM ALERGENÓW.
- Author
-
TRZCIŃSKA, MARIA and WILK, MARTA
- Abstract
Copyright of Science, Nature, Technologies / Nauka, Przyroda, Technologie is the property of Science Nature Technologies and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
- Published
- 2015
- Full Text
- View/download PDF
48. Immunoglobulin E and immunoglobulin G cross-reactive allergens and epitopes between cow milk αS1-casein and soybean proteins.
- Author
-
Cong, Yanjun, Li, Ye, and Li, Linfeng
- Subjects
- *
IMMUNOGLOBULIN E , *SOY proteins , *IMMUNOGLOBULIN G , *SOYMILK , *EPITOPES , *ALLERGENS - Abstract
Some infants allergic to cow milk–based formula are also sensitive to soybean-based formula. This paper aimed to explore the association of IgE and IgG cross-reactivity between α S1 -casein in cow milk (CM) and soybean proteins. The IgE and IgG cross-reactive allergens and epitopes were identified using sera from infants allergic to CM or mice monoclonal antibodies. The AA sequence alignment was performed using bioinformatics software. Finally, the digestion and heating stability of the cross-reactive allergen were explored by sodium dodecyl sulfate (SDS)-PAGE and Western blotting. The results showed that the IgE and IgG cross-reactive allergen was α subunit of β-conglycinin named Gly m Bd 60K. The IgE and IgG epitopes were the sequences at AA 319–341 and AA 164–182. No intact Gly m Bd 60K allergen could be observed after 2 min in simulated gastric fluid by SDS-PAGE. Heating did not change IgE and IgG cross-reactivity by Western blotting. Therefore, the existence of cross-reactivity between CM α S1 -casein and soybean proteins possibly contributes to the frequently observed cosensitization for these allergens in cow milk–allergic patients. The same IgE- and IgG-binding epitopes of cross-reactive allergens may provide important information for elucidation of the association between IgG and IgE antibody generation. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
49. Does Lidocaine Cause False Positive Results on Cocaine Urine Drug Screen?
- Author
-
Kim, Eungjae, Murray, Brian Patrick, Salehi, Maryam, Moran, Tim P., Carpenter, Joseph E., Koch, David D., Ritchie, James C., Schindler, Joanna M., and Morgan, Brent W.
- Published
- 2019
- Full Text
- View/download PDF
50. Sensitisation to lipid transfer proteins in pollen - allergic adults with food allergy.
- Author
-
Wawrzeńczyk, Adam, Żbikowska-Gotz, Magdalena, Wawrzeńczyk, Anna, and Bartuzi, Zbigniew
- Subjects
LIPID transfer protein ,ALLERGIC rhinitis ,FOOD allergy ,RESPIRATORY therapy ,IMMUNOGLOBULIN E ,ANTIGENS - Abstract
Introduction: Food allergy affects 6-17% of Europeans and in 60% of the cases it is accompanied by inhalation allergy. This is due to two phenomena, namely co-sensitisation and cross-reactivity, which are caused by panallergens, such as lipid transfer proteins (LTP). These proteins are classified as defence proteins PR-14 and are responsible for protecting the plant from bacterial and fungal infections. Clinically, LTP allergy manifests with severe anaphylactic reactions or milder reactions, such as oral allergy syndrome. Aim: To assess the incidence of specific IgE to components belonging to LTP based on molecular testing. Material and methods: The study was conducted at the Department of Allergy, Clinical Immunology and Internal Diseases in Bydgoszcz, Poland. A total of 50 subjects participated in the study. Each subject had their asIgE levels determined with ImmunoCap ISAC. Results and Conclusions: Antigen-specific IgE antibodies to LTP components were identified in 24% of the subjects. In subjects with LTP allergy, adverse skin reactions were the most common after consumption of sensitising foods. Peach was the most common food allergen triggering these reactions. The Artemisia vulgaris component Art v 3 was the precursor of LTP allergy in our study population: the highest incidence and the highest mean levels of asIgE were demonstrated for this component. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.